Clinical Trials Browser

Terminated × Interventional × tetrathiomolybdate × Clear all

NCT00195091 2025-05-16

Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer

Phase 2 Terminated

16 enrolled 5 charts

Breast Neoplasms

NCT00674557 2013-07-10

Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer

Phase 2 Terminated

Breast Neoplasms

NCT00352742 2008-10-28

A Study of ATN-224 and Bortezomib in Patients With Multiple Myeloma

Phase 1/2 Terminated

Multiple Myeloma, Recurrence